These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 32948003)

  • 1. Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development.
    Pasco ST; Anguita J
    Cells; 2020 Sep; 9(9):. PubMed ID: 32948003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design.
    Covián C; Fernández-Fierro A; Retamal-Díaz A; Díaz FE; Vasquez AE; Lay MK; Riedel CA; González PA; Bueno SM; Kalergis AM
    Front Immunol; 2019; 10():2806. PubMed ID: 31849980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCG-induced protection: effects on innate immune memory.
    Netea MG; van Crevel R
    Semin Immunol; 2014 Dec; 26(6):512-7. PubMed ID: 25444548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity.
    Parmar K; Siddiqui A; Nugent K
    Am J Med Sci; 2021 Jun; 361(6):683-689. PubMed ID: 33705721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis?
    Basak P; Sachdeva N; Dayal D
    Bioessays; 2021 Mar; 43(3):e2000200. PubMed ID: 33169410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
    Charoenlap S; Piromsopa K; Charoenlap C
    Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are BCG-induced non-specific effects adequate to provide protection against COVID-19?
    Vashishtha VM
    Hum Vaccin Immunother; 2021 Jan; 17(1):88-91. PubMed ID: 32762516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the BCG vaccine a useful tool against COVID-19?
    Zhelezova G; Mateeva V; Mateev G
    Clin Dermatol; 2021; 39(1):98-103. PubMed ID: 33972060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous vaccine interventions: boosting immunity against future pandemics.
    Marín-Hernández D; Nixon DF; Hupert N
    Mol Med; 2021 May; 27(1):54. PubMed ID: 34058986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination.
    Vierboom MPM; Dijkman K; Sombroek CC; Hofman SO; Boot C; Vervenne RAW; Haanstra KG; van der Sande M; van Emst L; Domínguez-Andrés J; Moorlag SJCFM; Kocken CHM; Thole J; Rodríguez E; Puentes E; Martens JHA; van Crevel R; Netea MG; Aguilo N; Martin C; Verreck FAW
    Cell Rep Med; 2021 Jan; 2(1):100185. PubMed ID: 33521699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
    Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
    Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of Nucleotide Oligomerization Domain and Toll-Like Receptors 2 to Enhance the Effect of Bacillus Calmette Guerin Immunization for Prevention of Mycobacterium Tuberculosis Infection: Protocol for a Series of Preclinical Randomized Controlled Trials.
    Eisenhut M
    JMIR Res Protoc; 2019 Jun; 8(6):e13045. PubMed ID: 31199313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trained innate immunity and resistance to Mycobacterium tuberculosis infection.
    Koeken VACM; Verrall AJ; Netea MG; Hill PC; van Crevel R
    Clin Microbiol Infect; 2019 Dec; 25(12):1468-1472. PubMed ID: 30807849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
    Behr MA; Divangahi M; Schurr E
    J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian rhythm influences induction of trained immunity by BCG vaccination.
    de Bree LCJ; Mourits VP; Koeken VA; Moorlag SJ; Janssen R; Folkman L; Barreca D; Krausgruber T; Fife-Gernedl V; Novakovic B; Arts RJ; Dijkstra H; Lemmers H; Bock C; Joosten LA; van Crevel R; Benn CS; Netea MG
    J Clin Invest; 2020 Oct; 130(10):5603-5617. PubMed ID: 32692732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BCG Vaccine for COVID-19: First Verdict and Future Directions.
    Gonzalez-Perez M; Sanchez-Tarjuelo R; Shor B; Nistal-Villan E; Ochando J
    Front Immunol; 2021; 12():632478. PubMed ID: 33763077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacillus Calmette-Guérin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice.
    Zhang BZ; Shuai H; Gong HR; Hu JC; Yan B; Yuen TT; Hu YF; Yoon C; Wang XL; Hou Y; Lin X; Huang X; Li R; Au-Yeung YM; Li W; Hu B; Chai Y; Yue M; Cai JP; Ling GS; Hung IF; Yuen KY; Chan JF; Huang JD; Chu H
    JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35446790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG-induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next-generation vaccines.
    Foster M; Hill PC; Setiabudiawan TP; Koeken VACM; Alisjahbana B; van Crevel R
    Immunol Rev; 2021 May; 301(1):122-144. PubMed ID: 33709421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.